Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Teck Resources
TECK
$32.9B
| $69.6M | 0.06% |
3,019,800
+712,400
| +31% | +$16M |
|
|
DENN
377
DELISTED
Denny's
DENN
| $69.6M | 0.06% |
3,391,000
-215,500
| -6% | -$4.14M |
|
378
Alcoa
AA
$13.8B
| $69M | 0.06% |
2,948,496
+549,600
| +23% | +$13.7M |
|
379
TIM SA
TIMB
$8.71B
| $68.7M | 0.06% |
4,590,338
+182,800
| +4% | +$2.65M |
|
380
Roper Technologies
ROP
$38.9B
| $68.3M | 0.06% |
+186,500
| New | +$66.2M |
|
|
CAJ
381
DELISTED
Canon, Inc.
CAJ
| $68.2M | 0.06% |
2,328,600
+126,705
| +6% | +$3.63M |
|
|
HPP
382
Hudson Pacific Properties
HPP
$767M
| $67.2M | 0.06% |
288,486
+15,900
| +6% | +$3.82M |
|
383
Mercado Libre
MELI
$95.5B
| $66.7M | 0.06% |
109,100
-125,200
| -53% | -$69.7M |
|
384
Dine Brands
DIN
$454M
| $66.7M | 0.06% |
698,500
+302,500
| +76% | +$27.6M |
|
385
Armstrong World Industries
AWI
$7.72B
| $65.9M | 0.06% |
678,300
+285,900
| +73% | +$25.6M |
|
386
Omega Healthcare
OHI
$13.9B
| $65.7M | 0.06% |
1,787,178
-71,452
| -4% | -$2.61M |
|
387
Emergent Biosolutions
EBS
$231M
| $65.2M | 0.06% |
1,350,511
-627,891
| -32% | -$30.1M |
|
388
Five Below
FIVE
$13B
| $64.8M | 0.06% |
540,000
-260,403
| -33% | -$34.3M |
|
|
ISCA
389
DELISTED
International Speedway Corp
ISCA
| $64.7M | 0.06% |
1,441,841
+11,728
| +0.8% | +$518K |
|
390
Fluor
FLR
$7.02B
| $64.7M | 0.06% |
1,919,600
+760,800
| +66% | +$25.5M |
|
391
Apple Hospitality REIT
APLE
$3.7B
| $64.7M | 0.06% |
4,076,488
+668,400
| +20% | +$10.8M |
|
392
Norfolk Southern
NSC
$75.1B
| $64.6M | 0.06% |
+324,200
| New | +$64.3M |
|
393
Banco Santander Chile
BSAC
$16.3B
| $64.6M | 0.06% |
2,158,527
-190,300
| -8% | -$5.52M |
|
|
DISH
394
DELISTED
DISH Network Corp.
DISH
| $64.4M | 0.06% |
1,676,400
+734,500
| +78% | +$26.1M |
|
395
Colliers International
CIGI
$5.2B
| $64.2M | 0.06% |
895,900
+28,199
| +3% | +$1.86M |
|
|
IPG
396
DELISTED
Interpublic Group of Companies
IPG
| $64.1M | 0.06% |
2,835,500
-1,736,500
| -38% | -$38.6M |
|
397
Omnicom Group
OMC
$23.4B
| $63.5M | 0.06% |
775,400
-84,700
| -10% | -$6.68M |
|
|
TTM
398
DELISTED
Tata Motors Limited
TTM
| $63.2M | 0.06% |
5,412,000
+487,100
| +10% | +$6.62M |
|
|
PRO
399
DELISTED
PROS Holdings
PRO
| $63.1M | 0.06% |
997,000
+691,300
| +226% | +$36.4M |
|
400
SEI Investments
SEIC
$12.6B
| $62.8M | 0.06% |
1,120,226
+149,900
| +15% | +$8.08M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.